J. Biol. Chem., Vol. 264, Issue 26, 15344-15350, Sep, 1989
Role of phosphatidylinositol in cardiac sarcolemmal membrane sodium- calcium exchange
GN Pierce and V Panagia
Division of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Canada.
The purpose of this investigation was to study the effects of a distinct
type of phospholipase C on sarcolemmal Na+-Ca2+ exchange. With this
phospholipase C (Staphylococcus aureus), treatment of cardiac sarcolemmal
vesicles resulted in a specific hydrolysis of membrane
phosphatidylinositol. This hydrolysis of phosphatidylinositol also released
two proteins (110 and 36 kDa) from the sarcolemmal membrane. Phospholipase
C pretreatment of the sarcolemma resulted in an unexpected stimulation of
Na+-Ca2+ exchange. The Vmax of Na+-Ca2+ exchange was increased but the Km
for Ca2+ was not altered. This stimulation was specific to the Na+-Ca2+
exchange pathway. ATP- dependent Ca2+ uptake was depressed after
phospholipase C treatment, but passive membrane permeability to Ca2+ was
unaffected. Sarcolemmal Na+,K+-ATPase activity was not altered, whereas
passive Ca2+ binding was modestly decreased after phospholipase C
pretreatment. The stimulation of Na+-Ca2+ exchange after
phosphatidylinositol hydrolysis was greater in inside-out vesicles than in
a total population of vesicles of mixed orientation. This finding suggests
that the cardiac sarcolemmal Na+-Ca2+ exchanger is functionally
asymmetrical. The results also suggest that membrane phosphatidylinositol
is inhibitory to the Na+-Ca2+ exchanger or, alternatively, this
phospholipid may anchor an endogenous inhibitory protein in the sarcolemmal
membrane. The observation that a transsarcolemmal Ca2+ flux pathway may be
stimulated solely by phosphatidylinositol hydrolysis independently of
phosphoinositide metabolic products like inositol triphosphate is novel.